Physician profile
Rachel E Acuff
NPI 1164640769
$3,542.40
in general payments reported to CMS, 2019-2025
35 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $802 · 2020: $353 · 2021: $717 · 2022: $588 · 2023: $344 · 2024: $376 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,082.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $505.73 | 2019-2022 | |
| Therapeuticsmd, INC. | $312.29 | 2019-2022 | |
| Aspira Women'S Health INC | $268.54 | 2021-2023 | Ova1 |
| Pfizer INC. | $252.79 | 2019-2025 | |
| Hologic Sales and Service, LLC | $251.27 | 2019-2025 | Myosure Tissue Removal Device, Aptima, Fluent Fluid Management System |
| Astellas Pharma US INC | $183.25 | 2023-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $161.71 | 2021-2025 | |
| Exeltis, USA INC. | $138.98 | 2020-2025 | Slynd |
| Daiichi Sankyo INC. | $126.99 | 2019-2021 | |
| Minerva Surgical, INC | $120.54 | 2020-2025 | |
| Novo Nordisk INC | $105.66 | 2019 | |
| Sanara Medtech INC. | $101.29 | 2020 | |
| Evofem Biosciences, INC. | $97.15 | 2021 | |
| Channel Medsystems, INC. | $94.89 | 2022 | |
| Shield Therapeutics INC | $86.35 | 2023-2025 | Accrufer |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $81.05 | 2022-2025 | |
| Avion Pharmaceuticals | $79.28 | 2019-2022 | |
| Scynexis, INC. | $71.18 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $56.22 | 2023-2025 | Gemtesa, Myfembree |
| Organon LLC | $54.58 | 2024 | |
| Mylan Pharmaceuticals INC. | $52.90 | 2019-2022 | |
| Myovant Sciences INC. | $51.77 | 2021 | |
| Sage Therapeutics, LLC | $51.47 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $37.63 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Agile Therapeutics, INC. | $34.30 | 2021-2024 | Twirla |
| Lupin INC. | $23.90 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $19.15 | 2025 | Qelbree |
| Conmed Corporation | $18.30 | 2019 | |
| Coopersurgical, INC. | $17.60 | 2023 | Wallach Cryosurgical Equipment |
| Boston Scientific Corporation | $16.85 | 2019 | |
| Medline Industries LP | $15.65 | 2024 | |
| Axonics, INC. | $15.33 | 2024 | Axonics |
| Vertex Pharmaceuticals Incorporated | $14.87 | 2025 | |
| Amag Pharmaceuticals, INC. | $11.94 | 2019 | |
| Meditrina | $11.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Acuff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.